Media coverage
1
Media coverage
Title A Pilot, Phase II, Open-Label, Single-Center Study of Sodium-Glucose Cotransporter-2 Inhibitor Empagliflozin in Major Depressive Disorder Media name/outlet Clinical Trials Daily Country/Territory United States Date 16/03/23 Persons Dan Vlad Iosifescu